CIA CPIA - Kimia Farma Head Audit
| KAEF Stock | IDR 540.00 5.00 0.92% |
Insider
CIA CPIA is Head Audit of Kimia Farma Persero
| Phone | 62 21 384 7709 |
| Web | https://kimiafarma.co.id |
Kimia Farma Management Efficiency
Kimia Farma's management efficiency ratios could be used to measure how well Kimia Farma manages its routine affairs as well as how well it operates its assets and liabilities.Kimia Farma Persero has accumulated 3.25 T in total debt with debt to equity ratio (D/E) of 1.09, which is about average as compared to similar companies. Kimia Farma Persero has a current ratio of 0.99, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Kimia Farma until it has trouble settling it off, either with new capital or with free cash flow. So, Kimia Farma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Kimia Farma Persero sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Kimia to invest in growth at high rates of return. When we think about Kimia Farma's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| SE Ak | Wijaya Karya Beton | 62 | |
| Hilda Yani | Indofarma Tbk | 48 | |
| Imam Baehaki | Adhi Karya Persero | 56 | |
| Engineer Waskito | Wijaya Karya Beton | 52 | |
| Engineer IPU | Wijaya Karya Beton | 58 | |
| Jejen Nugaha | Indofarma Tbk | 43 | |
| ST MBA | Wijaya Karya Beton | 53 | |
| Hananto Aji | Wijaya Karya Beton | 49 | |
| AAG Dharmawan | Adhi Karya Persero | 52 | |
| Arief Pramuhanto | Indofarma Tbk | 61 | |
| Agung Pranata | Jasa Marga Tbk | 36 | |
| SE CA | Indofarma Tbk | 47 | |
| Kamelia Faisal | Indofarma Tbk | 54 | |
| Kurniawan Suhartono | Kalbe Farma Tbk | 58 | |
| Fitri Wiyanti | Jasa Marga Tbk | 49 | |
| SE MM | Jasa Marga Tbk | 49 | |
| Lanny Soputro | Kalbe Farma Tbk | 59 | |
| Harum Zuhdi | Wijaya Karya Beton | 53 | |
| Pulung Prahasto | Adhi Karya Persero | 55 | |
| Alloysius Widigdo | Adhi Karya Persero | 47 | |
| Adriyanto Utomo | Adhi Karya Persero | 53 | |
Management Performance
| Return On Equity | -0.026 | |||
| Return On Asset | 0.0089 |
Kimia Farma Persero Leadership Team
Elected by the shareholders, the Kimia Farma's board of directors comprises two types of representatives: Kimia Farma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kimia. The board's role is to monitor Kimia Farma's management team and ensure that shareholders' interests are well served. Kimia Farma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kimia Farma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pujianto, Business Development Director | ||
| David Utama, Pres Director | ||
| I Wijaya, Finance Director | ||
| Jasmine Karsono, RD Marketing | ||
| Nurrachman, Independent Commissioner | ||
| CIA CPIA, Head Audit | ||
| Arief Pramuhanto, Human Capital and General Affairs Director | ||
| Honesti Basyir, President Director | ||
| Ganti Putro, Corporate Secretary | ||
| Dharma MM, HR Director | ||
| Verdi Budidarmo, Production and Supply Chain Director | ||
| Lina MM, F Director | ||
| MM Apt, Director Director | ||
| Untung Sutarjo, President Commissioner | ||
| Wahono Sumaryono, Independent Commissioner | ||
| Chrisma Albandjar, Commissioner | ||
| Eva Fairus, Gen Sales | ||
| Muhammad Fauzi, Commissioner | ||
| Rosrini, Compliance Mang |
Kimia Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kimia Farma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.026 | |||
| Return On Asset | 0.0089 | |||
| Profit Margin | (0.02) % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 14.62 T | |||
| Shares Outstanding | 5.55 B | |||
| Shares Owned By Insiders | 95.80 % | |||
| Shares Owned By Institutions | 0.07 % | |||
| Price To Book | 0.90 X | |||
| Price To Sales | 0.60 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Kimia Stock
Kimia Farma financial ratios help investors to determine whether Kimia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kimia with respect to the benefits of owning Kimia Farma security.